IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS? Cristina Festari, Daniele Altomare, Martina Bocchetta,

IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS?
Cristina Festari, Daniele Altomare, Martina Bocchetta, Cristina Muscio, Alessandro Padovani, Marina Boccardi, Giovanni B. Frisoni Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 12, Issue 7, Pages P22-P23 (July 2016) DOI: /j.jalz Copyright © Terms and Conditions

Figure Routine clinical work-up in AD and FTD patients (% of patients in different work-ups). Alzheimer's & Dementia: The Journal of the Alzheimer's Association , P22-P23DOI: ( /j.jalz ) Copyright © Terms and Conditions

IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS? Cristina Festari, Daniele Altomare, Martina Bocchetta,

Presentazioni simili

Presentazione sul tema: "IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS? Cristina Festari, Daniele Altomare, Martina Bocchetta,"— Transcript della presentazione:

Presentazioni simili

Sul progetto

Feed-back

Entrare

Autorizzarsi attraverso i social network:

IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS? Cristina Festari, Daniele Altomare, Martina Bocchetta,

Presentazioni simili

Presentazione sul tema: "IS THE INCREMENTAL DIAGNOSTIC VALUE OF AMYLOID-PET AFFECTED BY INFORMATION ON OTHER CORE BIOMARKERS? Cristina Festari, Daniele Altomare, Martina Bocchetta,"— Transcript della presentazione:

Presentazioni simili

Sul progetto

Feed-back